Terms: = Sarcomas AND TPR, P12270, 7175
22 results:
1. Intestinal infantile fibrosarcoma with translocation of NTRK. A case report and review of the literature.
Soler PM; Duque MSR; Juan GM; Terán AKC; Calvo ART; Cobo MLC
Rev Esp Patol; 2023; 56(2):76-81. PubMed ID: 37061245
[TBL] [Abstract] [Full Text] [Related]
2. NTRK -Rearranged Uterine sarcomas: Clinicopathologic Features of 15 Cases, Literature Review, and Risk Stratification.
Costigan DC; Nucci MR; Dickson BC; Chang MC; Song S; Sholl LM; Hornick JL; Fletcher CDM; Kolin DL
Am J Surg Pathol; 2022 Oct; 46(10):1415-1429. PubMed ID: 35713627
[TBL] [Abstract] [Full Text] [Related]
3. Novel fusion sarcomas including targetable NTRK and ALK.
Chen T; Wang Y; Goetz L; Corey Z; Dougher MC; Smith JD; Fox EJ; Freiberg AS; Flemming D; Fanburg-Smith JC
Ann Diagn Pathol; 2021 Oct; 54():151800. PubMed ID: 34464935
[TBL] [Abstract] [Full Text] [Related]
4. p53 immunohistochemical analysis of fusion-positive uterine sarcomas.
Mohammad N; Stewart CJR; Chiang S; Turashvili G; Dickson BC; Ng TL; Köbel M; McCluggage WG; Croce S; Lee CH
Histopathology; 2021 May; 78(6):805-813. PubMed ID: 33118176
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathological findings of pediatric NTRK fusion mesenchymal tumors.
Kang J; Park JW; Won JK; Bae JM; Koh J; Yim J; Yun H; Kim SK; Choi JY; Kang HJ; Kim WS; Shin JH; Park SH
Diagn Pathol; 2020 Sep; 15(1):114. PubMed ID: 32957984
[TBL] [Abstract] [Full Text] [Related]
6. Mesenchymal tumors of the gastrointestinal tract with NTRK rearrangements: a clinicopathological, immunophenotypic, and molecular study of eight cases, emphasizing their distinction from gastrointestinal stromal tumor (GIST).
Atiq MA; Davis JL; Hornick JL; Dickson BC; Fletcher CDM; Fletcher JA; Folpe AL; Mariño-Enríquez A
Mod Pathol; 2021 Jan; 34(1):95-103. PubMed ID: 32669612
[TBL] [Abstract] [Full Text] [Related]
7. A Case of Inv(1)(q23q31)
Rekhi B; Shetty O; Bapat P; Gurav M; Qureshi S
Int J Surg Pathol; 2021 Feb; 29(1):102-108. PubMed ID: 32489127
[TBL] [Abstract] [Full Text] [Related]
8. NTRK fusion cervical sarcoma: a report of three cases, emphasising morphological and immunohistochemical distinction from other uterine sarcomas, including adenosarcoma.
Rabban JT; Devine WP; Sangoi AR; Poder L; Alvarez E; Davis JL; Rudzinski E; Garg K; Bean GR
Histopathology; 2020 Jul; 77(1):100-111. PubMed ID: 31971278
[TBL] [Abstract] [Full Text] [Related]
9. NTRK Fusions Define a Novel Uterine Sarcoma Subtype With Features of Fibrosarcoma.
Chiang S; Cotzia P; Hyman DM; Drilon A; Tap WD; Zhang L; Hechtman JF; Frosina D; Jungbluth AA; Murali R; Park KJ; Soslow RA; Oliva E; Iafrate AJ; Benayed R; Ladanyi M; Antonescu CR
Am J Surg Pathol; 2018 Jun; 42(6):791-798. PubMed ID: 29553955
[TBL] [Abstract] [Full Text] [Related]
10. Constitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression.
Skrzypek K; Kusienicka A; Szewczyk B; Adamus T; Lukasiewicz E; Miekus K; Majka M
Oncotarget; 2015 Oct; 6(31):31378-98. PubMed ID: 26384300
[TBL] [Abstract] [Full Text] [Related]
11. Signal transduction and downregulation of C-MET in HGF stimulated low and highly metastatic human osteosarcoma cells.
Husmann K; Ducommun P; Sabile AA; Pedersen EM; Born W; Fuchs B
Biochem Biophys Res Commun; 2015 Sep; 464(4):1222-1227. PubMed ID: 26210452
[TBL] [Abstract] [Full Text] [Related]
12. Papillomavirus binding factor (PBF) is an intrinsically disordered protein with potential participation in osteosarcoma genesis, in silico evidence.
Castillo P; Cetina AF; Méndez-Tenorio A; Espinoza-Fonseca LM; Barrón BL
Theor Biol Med Model; 2014 Dec; 11():51. PubMed ID: 25471943
[TBL] [Abstract] [Full Text] [Related]
13. 1,25-Dihydroxyvitamin D(3) induction of the tissue-type plasminogen activator gene is mediated through its multihormone-responsive enhancer.
Merchiers P; Bulens F; Stockmans I; De Vriese A; Convents R; Bouillon R; Collen D; Belayew A; Carmeliet G
FEBS Lett; 1999 Oct; 460(2):289-96. PubMed ID: 10544252
[TBL] [Abstract] [Full Text] [Related]
14. Primary mediastinal nonseminomatous germ cell tumors: the influence of postchemotherapy pathology on long-term survival after surgery.
Kesler KA; Rieger KM; Ganjoo KN; Sharma M; Fineberg NS; Einhorn LH; Brown JW
J Thorac Cardiovasc Surg; 1999 Oct; 118(4):692-700. PubMed ID: 10504636
[TBL] [Abstract] [Full Text] [Related]
15. Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase.
Rodrigues GA; Park M
Mol Cell Biol; 1993 Nov; 13(11):6711-22. PubMed ID: 8413267
[TBL] [Abstract] [Full Text] [Related]
16. The tpr-MET oncogenic rearrangement is present and expressed in human gastric carcinoma and precursor lesions.
Soman NR; Correa P; Ruiz BA; Wogan GN
Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4892-6. PubMed ID: 2052572
[TBL] [Abstract] [Full Text] [Related]
17. Analysis by pulsed field gel electrophoresis reveals complex rearrangements in two MET alleles in a chemically-treated human cell line, MNNG-HOS.
Testa JR; Park M; Blair DG; Kalbakji A; Arden K; Vande Woude GF
Oncogene; 1990 Oct; 5(10):1565-71. PubMed ID: 2250912
[TBL] [Abstract] [Full Text] [Related]
18. tpr-MET oncogenic rearrangement: detection by polymerase chain reaction amplification of the transcript and expression in human tumor cell lines.
Soman NR; Wogan GN; Rhim JS
Proc Natl Acad Sci U S A; 1990 Jan; 87(2):738-42. PubMed ID: 2300559
[TBL] [Abstract] [Full Text] [Related]
19. Two rearranged MET alleles in MNNG-HOS cells reveal the orientation of MET on chromosome 7 to other markers tightly linked to the cystic fibrosis locus.
Park M; Testa JR; Blair DG; Parsa NZ; Vande Woude GF
Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2667-71. PubMed ID: 3282234
[TBL] [Abstract] [Full Text] [Related]
20. Characterization of the tpr-MET oncogene p65 and the MET protooncogene p140 protein-tyrosine kinases.
Gonzatti-Haces M; Seth A; Park M; Copeland T; Oroszlan S; Vande Woude GF
Proc Natl Acad Sci U S A; 1988 Jan; 85(1):21-5. PubMed ID: 3277171
[TBL] [Abstract] [Full Text] [Related]
[Next]
